Celltrion
068270.KS
#713
Rank
โ‚น2.468 T
Marketcap
โ‚น11,308
Share price
0.00%
Change (1 day)
0.81%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2023 (TTM): โ‚น245.26

According to Celltrion 's latest financial reports the company's current EPS (TTM) is โ‚น260.09. In 2022 the company made an earnings per share (EPS) of โ‚น253.20 a decrease over its 2021 EPS that were of โ‚น300.86.

EPS history for Celltrion from 2007 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น245.26-3.14%
2022โ‚น253.20-15.84%
2021โ‚น300.8612.77%
2020โ‚น266.7970.79%
2019โ‚น156.2115.63%
2018โ‚น135.09-33.13%
2017โ‚น202.04141.17%
2016โ‚น83.788.28%
2015โ‚น77.3711.28%
2014โ‚น69.5316.37%
2013โ‚น59.75-67.42%
2012โ‚น183.4084.22%
2011โ‚น99.5662.13%
2010โ‚น61.4180.61%
2009โ‚น34.00-559.63%
2008-โ‚น7.40-123.16%
2007โ‚น31.94